Table of Contents Author Guidelines Submit a Manuscript
AIDS Research and Treatment
Volume 2014, Article ID 237834, 8 pages
http://dx.doi.org/10.1155/2014/237834
Clinical Study

Evaluation of a Smoking Cessation Program for HIV Infected Individuals in an Urban HIV Clinic: Challenges and Lessons Learned

1Department of Medicine, Division of Infectious Diseases, Rutgers New Jersey Medical School, Newark, NJ, USA
2Division of Infectious Diseases, Rutgers New Jersey Medical School, Ambulatory Care Center-Infectious Disease Practice, 140 Bergen Street, Newark, NJ 07103, USA
3Division of General Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA
4Department of Preventive Medicine and Community Health, Rutgers New Jersey Medical School, Newark, NJ, USA

Received 22 June 2014; Accepted 13 September 2014; Published 1 October 2014

Academic Editor: Robert R. Redfield

Copyright © 2014 Debra Chew et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. E. Burkhalter, C. M. Springer, R. Chhabra, J. S. Ostroff, and B. D. Rapkin, “Tobacco use and readiness to quit smoking in low-income HIV-infected persons,” Nicotine and Tobacco Research, vol. 7, no. 4, pp. 511–522, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. D. N. Burns, D. Hillman, J. D. Neaton et al., “Cigarette smoking, bacterial pneumonia, and other clinical outcomes in HIV-1 infection,” Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol. 13, no. 4, pp. 374–383, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Crothers, T. A. Griffith, K. A. McGinnis et al., “The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans,” Journal of General Internal Medicine, vol. 20, no. 12, pp. 1142–1145, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. J. G. Feldman, H. Minkoff, M. F. Schneider et al., “Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study,” The American Journal of Public Health, vol. 96, no. 6, pp. 1060–1065, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. E. R. Gritz, D. J. Vidrine, A. B. Lazev, B. C. Amick III, and R. C. Arduino, “Smoking behavior in a low-income multiethnic HIV/AIDS population,” Nicotine and Tobacco Research, vol. 6, no. 1, pp. 71–77, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. E. M. Mamary, D. Bahrs, and S. Martinez, “Cigarette smoking and the desire to quit among individuals living with HIV,” AIDS Patient Care and STDs, vol. 16, no. 1, pp. 39–42, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. M. S. Webb, P. A. Vanable, M. P. Carey, and D. C. Blair, “Cigarette smoking among HIV+ men and women: examining health, substance use, and psychosocial correlates across the smoking spectrum,” Journal of Behavioral Medicine, vol. 30, no. 5, pp. 371–383, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. S. R. Dube, A. McClave, C. James, R. Caraballo, R. Kaufmann, and T. Pechacek, “Vital signs: current cigarette smoking among adults aged 18 years—United States, 2009,” Morbidity & Mortality Weekly Report, vol. 59, no. 35, pp. 1135–1140, 2010. View at Google Scholar
  9. A. R. Lifson, J. Neuhaus, J. R. Arribas, M. D. van Berg-Wolf, A. M. Labriola, and T. R. H. Read, “Smoking-related health risks among persons with HIV in the strategies for management of antiretroviral therapy clinical trial,” The American Journal of Public Health, vol. 100, no. 10, pp. 1896–1903, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Friis-Møller, P. Reiss, C. A. Sabin et al., “Class of antiretroviral drugs and the risk of myocardial infarction,” New England Journal of Medicine, vol. 356, no. 17, pp. 1723–1735, 2007. View at Google Scholar
  11. N. Friis-Møller, C. A. Sabin, R. Weber et al., “Combination antiretroviral therapy and the risk of myocardial infarction,” The New England Journal of Medicine, vol. 349, no. 21, pp. 1993–2003, 2003. View at Publisher · View at Google Scholar
  12. K. Crothers, A. A. Butt, C. L. Gibert, M. C. Rodriguez-Barradas, S. Crystal, and A. C. Justice, “Increased COPD among HIV-positive compared to HIV-negative veterans,” Chest, vol. 130, no. 5, pp. 1326–1333, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. P. T. Diaz, M. A. King, E. R. Pacht et al., “Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers,” Annals of Internal Medicine, vol. 132, no. 5, pp. 369–372, 2000. View at Google Scholar · View at Scopus
  14. A. K. Chaturvedi, R. M. Pfeiffer, L. Chang, J. J. Goedert, R. J. Biggar, and E. A. Engels, “Elevated risk of lung cancer among people with AIDS,” AIDS, vol. 21, no. 2, pp. 207–213, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. E. A. Engels, M. V. Brock, J. Chen, C. M. Hooker, M. Gillison, and R. D. Moore, “Elevated incidence of lung cancer among HIV-infected individuals,” Journal of Clinical Oncology, vol. 24, no. 9, pp. 1383–1388, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. G. D. Kirk, C. Merlo, P. O’Driscoll et al., “HIV infection is associated with an increased risk for lung cancer, independent of smoking,” Clinical Infectious Diseases, vol. 45, no. 1, pp. 103–110, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. L. J. Conley, T. J. Bush, S. P. Buchbinder, K. A. Penley, F. N. Judson, and S. D. Holmberg, “The association between cigarette smoking and selected HIV-related medical conditions,” AIDS, vol. 10, no. 10, pp. 1121–1126, 1996. View at Google Scholar · View at Scopus
  18. F. M. Gordin, M. P. Roediger, P.-M. Girard et al., “Pneumonia in HIV-infected persons: increased risk with cigarette smoking and treatment interruption,” The American Journal of Respiratory and Critical Care Medicine, vol. 178, no. 6, pp. 630–636, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. M. J. Miguez-Burbano, X. Burbano, D. Ashkin et al., “Impact of tobacco use on the development of opportunistic respiratory infections in HIV seropositive patients on antiretroviral therapy,” Addiction Biology, vol. 8, no. 1, pp. 39–43, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Turner, K. Page-Shafer, D. P. Chin et al., “Adverse impact of cigarette smoking on dimensions of health-related quality of life in persons with HIV infection,” AIDS Patient Care and STDs, vol. 15, no. 12, pp. 615–624, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. D. J. Vidrine, R. C. Arduino, and E. R. Gritz, “The effects of smoking abstinence on symptom burden and quality of life among persons living with HIV/AIDS,” AIDS Patient Care and STDs, vol. 21, no. 9, pp. 659–666, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Elzi, D. Spoerl, J. Voggensperger et al., “A smoking cessation programme in HIV-infected individuals: a pilot study,” Antiviral Therapy, vol. 11, no. 6, pp. 787–795, 2006. View at Google Scholar · View at Scopus
  23. G. L. Humfleet, S. M. Hall, K. L. Delucchi, and J. W. Dilley, “A randomized clinical trial of smoking cessation treatments provided in HIV clinical care settings,” Nicotine and Tobacco Research, vol. 15, no. 8, pp. 1436–1445, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. K. S. Ingersoll, K. L. Cropsey, and C. J. Heckman, “A test of motivational plus nicotine replacement interventions for HIV positive smokers,” AIDS and Behavior, vol. 13, no. 3, pp. 545–554, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. E. E. Lloyd-Richardson, C. A. Stanton, G. D. Papandonatos et al., “Motivation and patch treatment for HIV+ smokers: a randomized controlled trial,” Addiction, vol. 104, no. 11, pp. 1891–1900, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. D. J. Vidrine, R. M. Marks, R. C. Arduino, and E. R. Gritz, “Efficacy of cell phone-delivered smoking cessation counseling for persons living with HIV/AIDS: 3-month outcomes,” Nicotine and Tobacco Research, vol. 14, no. 1, pp. 106–110, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. M. E. Wewers, J. L. Neidig, and K. E. Kihm, “The feasibility of a nurse-managed, peer-led tobacco cessation intervention among HIV-positive smokers,” The Journal of the Association of Nurses in AIDS Care, vol. 11, no. 6, pp. 37–44, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. A. K. Matthews, M. Conrad, L. Kuhns, M. Vargas, and A. C. King, “Project exhale: preliminary evaluation of a tailored smoking cessation treatment for HIV-positive African American smokers,” AIDS Patient Care and STDs, vol. 27, no. 1, pp. 22–32, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. A. B. Moadel, S. L. Bernstein, R. J. Mermelstein, J. H. Arnsten, E. H. Dolce, and J. Shuter, “A randomized controlled trial of a tailored group smoking cessation intervention for HIV-infected smokers,” Journal of Acquired Immune Deficiency Syndromes, vol. 61, no. 2, pp. 208–215, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Pedrol-Clotet, E. Deig-Comerma, M. Ribell-Bachs, I. Vidal-Castell, P. García-Rodríguez, and A. Soler, “Bupropion use for smoking cessation in HIV-infected patients receiving antiretroviral therapy,” Enfermedades Infecciosas y Microbiologia Clinica, vol. 24, no. 8, pp. 509–511, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Tornero and C. Mafé, “Varenicline and antiretroviral therapy in patients with HIV,” Journal of Acquired Immune Deficiency Syndromes, vol. 52, no. 5, article 656, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. T. F. Heatherton, L. T. Kozlowski, R. C. Frecker, and K.-O. Fagerstrom, “The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire,” British Journal of Addiction, vol. 86, no. 9, pp. 1119–1127, 1991. View at Publisher · View at Google Scholar · View at Scopus
  33. C. C. DiClemente, J. O. Prochaska, S. K. Fairhurst, W. F. Velicer, M. M. Velasquez, and J. S. Rossi, “The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change,” Journal of Consulting and Clinical Psychology, vol. 59, no. 2, pp. 295–304, 1991. View at Publisher · View at Google Scholar · View at Scopus
  34. M. C. Fiore, C. R. Jaen, T. B. Baker et al., Treating Tobacco Use and Dependence: Clinical Practice Guideline, U.S. Department of Health and Human Services. Public Health Service, Rockville, Md, USA, 2008.
  35. G. L. Humfleet, K. Delucchi, K. Kelley, S. M. Hall, J. Dilley, and G. Harrison, “Characteristics of HIV-positive cigarette smokers: a sample of smokers facing multiple challenges,” AIDS Education and Prevention, vol. 21, no. 3, pp. 54–64, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Shuter, S. L. Bernstein, and A. B. Moadel, “Cigarette smoking behaviors and beliefs in persons living with HIV/AIDS,” The American Journal of Health Behavior, vol. 36, no. 1, pp. 75–85, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. J. M. Williams and D. Ziedonis, “Addressing tobacco among individuals with a mental illness or an addiction,” Addictive Behaviors, vol. 29, no. 6, pp. 1067–1083, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. R. M. McCool and K. P. Richter, “Why do so many drug users smoke?” Journal of Substance Abuse Treatment, vol. 25, no. 1, pp. 43–49, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. J. O. Prochaska, W. F. Velicer, J. M. Prochaska, and J. L. Johnson, “Size, consistency, and stability of stage effects for smoking cessation,” Addictive Behaviors, vol. 29, no. 1, pp. 207–213, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. P. Sheeran, “Intention—behavior relations: a conceptual and empirical review,” in European Review of Social Psychology, W. Stroebe and M. Hewstone, Eds., vol. 12, pp. 1–36, John Wiley & Sons, Chichester, UK, 2002. View at Google Scholar
  41. M. A. Chesney, “Factors affecting adherence to antiretroviral therapy,” Clinical Infectious Diseases, vol. 30, no. 2, pp. S171–S176, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. Panel on Antiretroviral Guidelines for Adults and Adolescents, “Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents,” Department of Health and Human Services, 2014, http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
  43. M. C. Fiore and T. B. Baker, “Treating smokers in the health care setting,” The New England Journal of Medicine, vol. 365, no. 13, pp. 1222–1231, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. K. Crothers, J. L. Goulet, M. C. Rodriguez-Barradas et al., “Decreased awareness of current smoking among health care providers of HIV-positive compared to HIV-negative veterans,” Journal of General Internal Medicine, vol. 22, no. 6, pp. 749–754, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. K. J. Horvath, M. Eastman, R. Prosser, B. Goodroad, and L. Worthington, “Addressing smoking during medical visits: patients with human immunodeficiency virus,” American Journal of Preventive Medicine, vol. 43, no. 5, supplement 3, pp. S214–S221, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Shuter, L. N. Salmo, A. D. Shuter, E. C. Nivasch, M. Fazzari, and A. B. Moadel, “Provider beliefs and practices relating to tobacco use in patients living with HIV/AIDS: a national survey,” AIDS and Behavior, vol. 16, no. 2, pp. 288–294, 2012. View at Publisher · View at Google Scholar · View at Scopus